Kypha's Series A Round

Kypha raised a round of funding on November 21, 2014.

Kypha, fka Kentucky Pharmaceuticals, seeks to discover, develop and commercialize innovative in-vitro diagnostic biomarker tests within the inflammation and autoimmune space. The company's plan is for…

Articles about Kypha's Series A Round: